ArticleNPJ digital medicine2026
AI Guided Parenteral Nutrition Therapy After Hematopoietic Stem Cell Transplantation.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adults undergoing hematopoietic cell transplantation often develop serious complications that cause rapid nutritional decline. We developed and evaluated an AI approach to standardize intravenous nutrition (total parenteral nutrition, TPN) during this vulnerable period. Using real-world records from Stanford Health Care (6402 transplants, 2008-2025), we analyzed 1473 adults who received TPN, totaling 27,447 patient-days, linking each day's clinical state to the next day's prescription. We created a library of 30 standardized TPN regimens and trained a model to recommend next-day dose adjustments based on laboratory data and the existing prescription. (Pearson r ≈ 0.71). We then assessed an AI policy learned from past care and found that the Reinforcement learning agent selected dose adjustments with a higher composite score than the existing clinical policy. These results show that AI-guided TPN is feasible and may enhance bedside decision-making for adult transplant care, warranting prospective evaluation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.